NAROPIN (APP Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the NAROPIN drug offered from APP Pharmaceuticals, LLC. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | APP Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | ROPIVACAINE HYDROCHLORIDE MONOHYDRATE |
| SUBSTANCE NAME: | ROPIVACAINE HYDROCHLORIDE MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |
| ROUTE: | EPIDURAL; INFILTRATION; PERINEURAL |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-08-04 |
| END MARKETING DATE: | 0000-00-00 |
NAROPIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | NAROPIN from APP Pharmaceuticals, LLC |
| LABELER NAME: | APP Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2009-08-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-286_cb8b926d-cf66-bc7e-c940-e820fd4e877c |
| PRODUCT NDC: | 63323-286 |
| APPLICATION NUMBER: | NDA020533 |
Other ROPIVACAINE HYDROCHLORIDE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
